Secondly, combining with the results of the Cox analysis and Kaplan-Meier method, we found that high SLC12A5 expression correlated with worse overall survival of KIRC, LAML, PRAD, and UCEC, while it correlated with favorable overall survival of PAAD. Here, SLC12A5 is linked to pancreatic adenocarcinoma.